{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:07:33Z","timestamp":1790078853636,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12785-9","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:23:51Z","timestamp":1790076231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutational Spectrum of DMD Gene Variants and Cascade Screening Outcomes in the Central-Eastern Black Sea Region of T\u00fcrkiye: A Single-Centre Retrospective Study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-0380","authenticated-orcid":false,"given":"\u00c7a\u011fr\u0131","family":"Do\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-4383","authenticated-orcid":false,"given":"Seren","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"12785_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919\u2013928. https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4","journal-title":"Cell"},{"key":"12785_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Primers 7:13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3","journal-title":"Nat Rev Dis Primers"},{"key":"12785_CR3","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano MS, Scotton C, Passarelli C, Ferlini A (2015) Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 20:18168\u201318184. https:\/\/doi.org\/10.3390\/molecules201018168","journal-title":"Molecules"},{"key":"12785_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifir\u00f2 G (2020) Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis 15:141. https:\/\/doi.org\/10.1186\/s13023-020-01430-8","journal-title":"Orphanet J Rare Dis"},{"key":"12785_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13018-022-02996-8","volume":"17","author":"N Salari","year":"2022","unstructured":"Salari N, Fatahi B, Valipour E et al (2022) Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis. J Orthop Surg Res 17:96. https:\/\/doi.org\/10.1186\/s13018-022-02996-8","journal-title":"J Orthop Surg Res"},{"key":"12785_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","volume":"2","author":"AP Monaco","year":"1988","unstructured":"Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90\u201395. https:\/\/doi.org\/10.1016\/0888-7543(88)90113-9","journal-title":"Genomics"},{"key":"12785_CR7","doi-asserted-by":"publisher","first-page":"1360224","DOI":"10.3389\/fgene.2024.1360224","volume":"15","author":"F Gatto","year":"2024","unstructured":"Gatto F, Benemei S, Piluso G, Bello L (2024) The complex landscape of DMD mutations: moving towards personalized medicine. Front Genet 15:1360224. https:\/\/doi.org\/10.3389\/fgene.2024.1360224","journal-title":"Front Genet"},{"key":"12785_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT (2006) Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 34:135\u2013144. https:\/\/doi.org\/10.1002\/mus.20586","journal-title":"Muscle Nerve"},{"key":"12785_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S et al (2015) The TREAT-NMD DMD Global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat 36:395\u2013402. https:\/\/doi.org\/10.1002\/humu.22758","journal-title":"Hum Mutat"},{"key":"12785_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","volume":"30","author":"S Tuffery-Giraud","year":"2009","unstructured":"Tuffery-Giraud S, B\u00e9roud C, Leturcq F et al (2009) Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat 30:934\u2013945. https:\/\/doi.org\/10.1002\/humu.20976","journal-title":"Hum Mutat"},{"key":"12785_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"JR Mendell","year":"2016","unstructured":"Mendell JR, Goemans N, Lowes LP et al (2016) Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol 79:257\u2013271. https:\/\/doi.org\/10.1002\/ana.24555","journal-title":"Ann Neurol"},{"key":"12785_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DDDT.S97635","volume":"11","author":"KR Lim","year":"2017","unstructured":"Lim KR, Maruyama R, Yokota T (2017) Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther 11:533\u2013545. https:\/\/doi.org\/10.2147\/DDDT.S97635","journal-title":"Drug Des Devel Ther"},{"key":"12785_CR13","doi-asserted-by":"publisher","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","volume":"94","author":"DE Frank","year":"2020","unstructured":"Frank DE, Schnell FJ, Akana C et al (2020) Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy. Neurology 94:e2270\u2013e2282. https:\/\/doi.org\/10.1212\/WNL.0000000000009233","journal-title":"Neurology"},{"key":"12785_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","volume":"77","author":"PR Clemens","year":"2020","unstructured":"Clemens PR, Rao VK, Connolly AM et al (2020) Safety, tolerability, and efficacy of viltolarsen in boys with Duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 randomized clinical trial. JAMA Neurol 77:982\u2013991. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1264","journal-title":"JAMA Neurol"},{"key":"12785_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/mus.27347","volume":"64","author":"KR Wagner","year":"2021","unstructured":"Wagner KR, Kuntz NL, Koenig E et al (2021) Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: a randomized, double-blind, placebo-controlled, dose-titration trial. Muscle Nerve 64:285\u2013292. https:\/\/doi.org\/10.1002\/mus.27347","journal-title":"Muscle Nerve"},{"key":"12785_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/humu.20918","volume":"30","author":"A Aartsma-Rus","year":"2009","unstructured":"Aartsma-Rus A, Fokkema I, Verschuuren J et al (2009) Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat 30:293\u2013299. https:\/\/doi.org\/10.1002\/humu.20918","journal-title":"Hum Mutat"},{"key":"12785_CR17","doi-asserted-by":"publisher","first-page":"402369","DOI":"10.1155\/2013\/402369","volume":"2013","author":"Y Aoki","year":"2013","unstructured":"Aoki Y, Yokota T, Wood MJ (2013) Development of multiexon skipping antisense oligonucleotide therapy for Duchenne muscular dystrophy. Biomed Res Int 2013:402369. https:\/\/doi.org\/10.1155\/2013\/402369","journal-title":"Biomed Res Int"},{"key":"12785_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2350-13-73","volume":"13","author":"S Brioschi","year":"2012","unstructured":"Brioschi S, Gualandi F, Scotton C et al (2012) Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype. BMC Med Genet 13:73. https:\/\/doi.org\/10.1186\/1471-2350-13-73","journal-title":"BMC Med Genet"},{"key":"12785_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cge.12048","volume":"84","author":"E Viggiano","year":"2013","unstructured":"Viggiano E, Picillo E, Cirillo A, Politano L (2013) Comparison of X-chromosome inactivation in Duchenne muscle\/myocardium-manifesting carriers, non-manifesting carriers and related daughters. Clin Genet 84:265\u2013270. https:\/\/doi.org\/10.1111\/cge.12048","journal-title":"Clin Genet"},{"key":"12785_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nmd.2010.05.010","volume":"20","author":"P Soltanzadeh","year":"2010","unstructured":"Soltanzadeh P, Friez MJ, Dunn D et al (2010) Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord 20:499\u2013504. https:\/\/doi.org\/10.1016\/j.nmd.2010.05.010","journal-title":"Neuromuscul Disord"},{"key":"12785_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","volume":"28","author":"M Ishizaki","year":"2018","unstructured":"Ishizaki M, Kobayashi M, Adachi K, Matsumura T, Kimura E (2018) Female dystrophinopathy: review of current literature. Neuromuscul Disord 28:572\u2013581. https:\/\/doi.org\/10.1016\/j.nmd.2018.04.005","journal-title":"Neuromuscul Disord"},{"key":"12785_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17:347\u2013361. https:\/\/doi.org\/10.1016\/S1474-4422(18)30025-5","journal-title":"Lancet Neurol"},{"key":"12785_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nmd.2019.06.005","volume":"29","author":"G Toksoy","year":"2019","unstructured":"Toksoy G, Durmus H, Aghayev A et al (2019) Mutation spectrum of 260 dystrophinopathy patients from Turkey and important highlights for genetic counseling. Neuromuscul Disord 29:601\u2013613. https:\/\/doi.org\/10.1016\/j.nmd.2019.06.005","journal-title":"Neuromuscul Disord"},{"key":"12785_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.12956\/tchd.913588","volume":"15","author":"B Cavdarli","year":"2021","unstructured":"Cavdarli B, Yayici Koken O, Ceylan AC, Semerci Gunduz CN, Topaloglu H (2021) Genetic landscape of dystrophin gene deletions and duplications from Turkey: a single center experience. Turkish J Pediatr Dis 15:319\u2013324. https:\/\/doi.org\/10.12956\/tchd.913588","journal-title":"Turkish J Pediatr Dis"},{"key":"12785_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10048-024-00765-9","volume":"25","author":"H Ozkalayci","year":"2024","unstructured":"Ozkalayci H, Bora E, Cankaya T et al (2024) Investigation of genotype-phenotype and familial features of Turkish dystrophinopathy patients. Neurogenetics 25:201\u2013213. https:\/\/doi.org\/10.1007\/s10048-024-00765-9","journal-title":"Neurogenetics"},{"key":"12785_CR26","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57. https:\/\/doi.org\/10.1093\/nar\/gnf056","journal-title":"Nucleic Acids Res"},{"key":"12785_CR27","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/sj.ejhg.5201465","volume":"13","author":"T Lalic","year":"2005","unstructured":"Lalic T, Vossen RH, Coffa J et al (2005) Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 13:1231\u20131234. https:\/\/doi.org\/10.1038\/sj.ejhg.5201465","journal-title":"Eur J Hum Genet"},{"key":"12785_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10048-004-0204-1","volume":"6","author":"B Janssen","year":"2005","unstructured":"Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J (2005) MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 6:29\u201335. https:\/\/doi.org\/10.1007\/s10048-004-0204-1","journal-title":"Neurogenetics"},{"key":"12785_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR et al (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37:564\u2013569. https:\/\/doi.org\/10.1002\/humu.22981","journal-title":"Hum Mutat"},{"key":"12785_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"12785_CR31","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT et al (2018) Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat 39:1517\u20131524. https:\/\/doi.org\/10.1002\/humu.23626","journal-title":"Hum Mutat"},{"key":"12785_CR32","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, de la Hoya M, Wiggins GAR et al (2023) Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet 110:1046\u20131067. https:\/\/doi.org\/10.1016\/j.ajhg.2023.06.002","journal-title":"Am J Hum Genet"},{"key":"12785_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM et al (2020) Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med 22:245\u2013257. https:\/\/doi.org\/10.1038\/s41436-019-0686-8","journal-title":"Genet Med"},{"key":"12785_CR34","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s00415-011-5979-z","volume":"258","author":"F Magri","year":"2011","unstructured":"Magri F, Govoni A, D\u2019Angelo MG et al (2011) Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol 258:1610\u20131623. https:\/\/doi.org\/10.1007\/s00415-011-5979-z","journal-title":"J Neurol"},{"key":"12785_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17:251\u2013267. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3","journal-title":"Lancet Neurol"},{"key":"12785_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77\u201393. https:\/\/doi.org\/10.1016\/S1474-4422(09)70271-6","journal-title":"Lancet Neurol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12785-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12785-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12785-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:23:53Z","timestamp":1790076233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12785-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12785"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12785-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial or non-financial interests relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki (2013 revision). Approval was granted by the Ordu University Non-Interventional Clinical Research Ethics Committee (Meeting No. 07, Decision No. 95, dated 10 April 2026).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because the study relied exclusively on anonymised archival clinical and laboratory data accumulated during routine diagnostic workup, the requirement for written informed consent was formally waived by the ethics committee.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript contains no individually identifiable data, images, or details; all patient identifiers are anonymised pseudonyms.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used generative AI-based tools solely to improve the language and readability of the text. No AI tools were used to generate, analyse, or interpret the study data, nor to produce or edit any of the figures. The authors reviewed and edited all output as needed and take full responsibility for the content of the publication.","order":5,"name":"Ethics","label":"Use of AI and AI-assisted technologies","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1600"}}